Skip to main navigation Skip to search Skip to main content

Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: Final results from a pivotal study

Anders Österborg, Roxanne C. Jewell, Swami Padmanabhan-Iyer, Thomas J. Kipps, Jiří Mayer, Stephan Stilgenbauer, Cathy D. Williams, Andrzej Hellmann, Richard R. Furman, Tadeusz Robak, Peter Hillmen, Marek Trnêný, Martin J.S. Dyer, Magdalena Piotrowska, Tomas Kozak, Ira V. Gupta, Jennifer L. Phillips, Nancy Goldstein, Herbert Struemper, Nedjad LosicSteen Lisby, William G. Wierda

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish (US)
Pages (from-to)e311-e314
JournalHaematologica
Volume100
Issue number8
DOIs
StatePublished - Aug 5 2015

Keywords

  • Fludarabine-refractory
  • Ofatumumab
  • Pivotal study

ASJC Scopus subject areas

  • Hematology

Cite this